This is a non-core endpoint: only basic statistics are computed.
L02BB Anti-androgens
RX_L02BB
No definition available.
Endpoint definition
↥392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
1 out of 7 registries used, show all original rules.
2465
Check minimum number of events
2465
Include endpoints None
2465
Remove individuals based on genotype QC
2384
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
L02BB Anti-androgens
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
- Any ICDMAIN event in hilmo or causes of death
- Any prescribed medicine buy
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 2384 | - | 2383 |
Unadjusted prevalence (%) | 0.63 | - | 1.43 |
Mean age at first event (years) | 71.35 | - | 71.36 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: RX_L02BB – L02BB Anti-androgens
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after L02BB Anti-androgens
↥Endpoint not on priority list, no data to show.